Press Release

NAT Wins FDA Research Grant on Critical Process Parameters of Amphotericin B Liposomes

Posted on

Littleton, MA, Oct. 1, 2016—Neo-Advent Technologies, LLC (NAT) of Littleton, MA, has been awarded a U.S. FDA research grant to evaluate “Critical Process Parameters for the Preparation of Amphotericin B Liposomes.” The objectives of this study are to determine the critical manufacturing process parameters of the liposomal drug amphotericin B using Quality by Design (QBD), […]